ASCO News: Two New Drugs Show Promise for Recurrent Ovarian Cancer
…serous or was related to a BRCA gene mutation, or change, received either olaparib by itself or olaparib plus cediranib. Researchers found that 80% of the women who received the…
News
Search Results
Finding Sparks, Fueling Motivation | Meet a Scientist
…for the laymen and women: our bodies have genes whose jobs are to keep our cells from becoming cancerous tumors. Sometimes these genes become mutated, such as the BRCA mutation,…
US Preventive Services Task Force: Ovarian Cancer Screening Not Effective for Low-Risk Women
…of the disease, or with BRCA1/2 genetic mutations. The complete recommendation was published in JAMA, with several accompanying editorials in related publications by experts in the field who offer their…
High-Grade Serous Carcinoma
…some patients, especially those with BRCA mutations. In 2020, PARP inhibitors received FDA approval as first-line therapy for a subset of patients with advanced ovarian cancers, and has been shown to…
Highlights from the March 2016 Society of Gynecologic Oncology (SGO) Annual Meeting on Women’s Cancer
…reported higher rates of clinically actionable multigene panel results in Ashkenazi Jewish patients, suggesting that panel testing should be offered to Ashkenazi Jewish patients who test negative for BRCA1/2. Andrew…
ACA Update
…risk-reducing surgeries or using chemoprevention. Furthermore, women with ovarian cancer caused by BRCA mutations might be eligible for new personalized therapies. 124 30 Affordable Care Act Update Read a statement…
Leading ovarian cancer organization announces 2017 honorees
…Cancer Research Center, and the Director of Gynecologic Oncology Research at the Basser Center for BRCA. A highly accomplished basic science researcher, the Prize recognizes his previous and ongoing research…
SGO 2020 Highlights
…potential precancerous sites in healthy fallopian tissue of postmenopausal BRCA1 mutation carriers, researchers found that further study is needed to determine whether these changes are evidence of the earliest stages…
Stand Up to Cancer Update Webinar
…on the role of the BRCA-Fanconi anemia pathway. She has been exploring how a better understanding of this pathway can lead to more effective therapies and prevention of ovarian cancers….
The Overview: February 2025
…Gong of Cleveland Clinic has been awarded the Liz Tilberis Research Prize for Outstanding Early Career Investigators for his work to advance knowledge of BRCA-mutant ovarian cancer. Learn more. New…
Discovery of New Gene Mutation That Increases Ovarian Cancer Risk, Passed Down Through Paternal Lineage
…completely independently of BRCA1/2. Keven Eng, the study’s author, explains that the research, “may explain why we find families with multiple affected daughters: because a dad’s chromosomes determine the sex…
Sponsor a Scientist
Support Cancer Research Funding: Sponsor a Scientist Sponsor a Scientist Funding OCRA’s scientific research initiatives is one of the most powerful ways to support our life-saving work. Contribute to Groundbreaking…